SEC Form 4 · accession 0000950138-19-000027
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hugh M. O'Neill
Officer — EVP & Chief Comm Ofcr
Period of report
Jan 3, 2019
Accepted (ET)
Jan 7, 2019 · 6:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jan 3, 2019 | F | 888 | $16.14 | D | 63,673 | D | |
| Ordinary Shares | Jan 4, 2019 | F | 430 | $17.21 | D | 63,243 | D |
Table II — derivative securities
No Table II lines on this filing.